As six-year-old tech unicorn PharmEasy acquires publicly-listed diagnostics chain Thyrocare, many believe it is a pivotal moment for startups in India
CEO Siddharth Shah says the strong bond between the five PharmEasy cofounders gives the company significant management bandwidth to create impact in every vertical
The cofounder added that PharmEasy’s vision is being a single platform for medical and health information, consultation, diagnostics, medicines and medical products
In the world of startups, some success stories are scripted because of the singular vision and focus of a solo entrepreneur, while others are about accommodating several leaders or cofounders on an equal footing. The latter is more often than not fraught with peril, with many a great-idea-turned-startup becoming untenable because of a clash or disagreement between cofounders.